Maze Therapeutics (MAZE) Short Interest
Nasdaq • MAZE • US5787841007
As of Oct 26, 2026, ORTEX estimated 21.2% of free float sold short, 9.2 days to cover, cost to borrow 0.5%. Sign up for live short interest data.
Nasdaq • MAZE • US5787841007
As of Oct 26, 2026, ORTEX estimated 21.2% of free float sold short, 9.2 days to cover, cost to borrow 0.5%. Sign up for live short interest data.
This page tracks how heavily Maze Therapeutics (Nasdaq:MAZE) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Maze Therapeutics (Nasdaq: MAZE) has a market capitalization of $1.88B. Last close $34.91 (as of 2026-11-10); 52-week range $21.95 to $53.65. ORTEX data as of 2026-10-26: short interest was 21.22% of free float, 9.2 days to cover and the average cost to borrow was 0.5%. Sign up for live short interest data.